With a sweep of a smartphone camera, waves of infrared light penetrate the skin and beam back biometrics based on blood flow. It sounds like science fiction, but this electro-optic technique – photoplethysmography (PPG) – is real and the subject of rising insurer interest due to its affordability and array of potential digital applications.
The trends and issues that will influence the development of the underwriting manual of the future
Designing effective applications means making it psychologically easy for applicants to answer questions honestly. In Insurance Thought Leadership (ITL), RGA's Peter Hovard makes the case for "positive friction," or prompts that encourage an applicant to offer a more considered, and accurate, response.
Accelerated underwriting has historically been a slow movement within the insurance industry, a panel acknowledged Monday at the 2022 Life Insurance Conference, sponsored by LIMRA, LOMA, Society of Actuaries and the American Council of Life Insurers.
The global pandemic’s toll on cancer diagnoses and what it may mean for the future of US life expectancy
The symptom of fatigue is one of the top five most frequently presented health complaints in primary care. Find out what underwriters should consider in the context of risk assessments for life insurance.
In this second interview of a 4-part series, Dr. Achim Regenauer answers questions relevant to Life & Health underwriters on advances in cancer diagnostics.
RGA's Dr. Maryam B. Shapland, Vice President and Medical Director, U.S. Mortality Markets, explores reactive thrombocytosis, a condition associated with higher mortality in acutely ill patients.
In this whitepaper, multiple RGA experts address the status quo of testing for the purposes of early disease detection and look forward to the future of screening.